PhRMA Federal Affairs Group Adds Two Former Hill Staffers
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal affairs team is in a period of transition with the upcoming departure of Senior VP Currie. Former staffers to Sen. Santorum, Rep. Regula are among new hires.
You may also be interested in...
Amgen Adds Two More PhRMA Lobbyists To D.C. Office
Amgen’s lobbying team will include PhRMA’s point person on FDA legislation (Mara Guarducci) and Medicare/reimbursement specialist (Scott Olsen). Both will report to Amgen’s newly named VP-Government Affairs Rodger Currie.
Medicare Reaffirms Faith In Formulary Review Process Ahead Of Part D Changes
Dramatic transformation in the US Medicare Part D benefit design does not require any changes to CMS’ overall approach to reviewing formulary submissions from private drug plan sponsors, the agency says in its final guidance implementing the design changes for 2025.
Cost-Based Pricing: The Real Threat Hiding In Latest US Drug Price Headlines
Bernie Sanders is back at it, getting headlines for demanding immediate price cuts to Novo’s blockbuster GLP-1 brands. But behind the familiar rhetoric is a newer threat: academic research on cost-based pricing that could one day feed into the emerging Medicare ‘negotiation’ system.